Canada - English - Health Canada

merck canada inc - aprepitant - capsule - 80mg - aprepitant 80mg - neurokinin-1 receptor antagonists

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - aprepitant 40mg - capsule - 40 mg - active: aprepitant 40mg excipient: hyprolose micronised sodium lauryl sulphate opaque white and mustard yellow hard gelatin capsule (contains titanium dioxide, yellow iron) microcrystalline cellulose purified water sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - not applicable

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - aprepitant -

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - aprepitant 125mg - capsule - 125 mg - active: aprepitant 125mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - aprepitant 165mg - capsule - 165 mg - active: aprepitant 165mg excipient: gelatin   hyprolose indigo carmine microcrystalline cellulose as beads sodium laurilsulfate sucrose titanium dioxide   - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - aprepitant - capsule - 125mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - aprepitant 1 cap (125mg) + 2 cap (80mg) - 1 cap (125mg) + 2 cap (80mg)

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - fosaprepitant - vomiting; cancer - antiemetics and antinauseants, - prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and paediatric patients aged 6 months and older.ivemend 150 mg is given as part of a combination therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - aprepitant -